loading
Harmony Biosciences Holdings Inc stock is traded at $26.27, with a volume of 336.00K. It is down -0.96% in the last 24 hours and down -18.84% over the past month. Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.
See More
Previous Close:
$26.54
Open:
$26.505
24h Volume:
336.00K
Relative Volume:
0.44
Market Cap:
$1.51B
Revenue:
$681.88M
Net Income/Loss:
$122.63M
P/E Ratio:
12.45
EPS:
2.11
Net Cash Flow:
$220.18M
1W Performance:
-1.14%
1M Performance:
-18.84%
6M Performance:
-9.89%
1Y Performance:
-24.53%
1-Day Range:
Value
$25.95
$26.50
1-Week Range:
Value
$25.95
$27.34
52-Week Range:
Value
$25.95
$41.61

Harmony Biosciences Holdings Inc Stock (HRMY) Company Profile

Name
Name
Harmony Biosciences Holdings Inc
Name
Phone
(484) 539-9800
Name
Address
630 W GERMANTOWN PIKE, PLYMOUTH MEETING
Name
Employee
268
Name
Twitter
Name
Next Earnings Date
2024-10-29
Name
Latest SEC Filings
Name
HRMY's Discussions on Twitter

Compare HRMY with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
HRMY
Harmony Biosciences Holdings Inc
26.27 1.53B 681.88M 122.63M 220.18M 2.11
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
407.56 104.55B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
469.33 60.36B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
560.46 59.84B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
800.99 49.07B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
330.86 35.16B 4.56B -176.77M 225.30M -1.7177

Harmony Biosciences Holdings Inc Stock (HRMY) Upgrades & Downgrades

Date Action Analyst Rating Change
Jul-21-25 Initiated Truist Buy
Jul-10-25 Resumed Goldman Neutral
Jun-02-25 Resumed Oppenheimer Outperform
Feb-11-25 Initiated Deutsche Bank Buy
Dec-17-24 Initiated H.C. Wainwright Buy
Oct-10-24 Resumed Raymond James Outperform
Sep-10-24 Initiated UBS Buy
Jun-21-24 Initiated Citigroup Buy
Jan-02-24 Downgrade BofA Securities Neutral → Underperform
Sep-25-23 Downgrade Goldman Neutral → Sell
Sep-07-23 Initiated Berenberg Buy
Apr-20-23 Initiated BofA Securities Neutral
Oct-14-22 Upgrade Janney Neutral → Buy
Oct-14-22 Upgrade Jefferies Hold → Buy
Aug-03-22 Downgrade Jefferies Buy → Hold
Jul-13-22 Downgrade Goldman Buy → Neutral
Jul-07-22 Initiated Mizuho Buy
Apr-14-22 Initiated Cantor Fitzgerald Overweight
Dec-01-21 Initiated Oppenheimer Outperform
Nov-04-21 Initiated Raymond James Outperform
Sep-23-21 Initiated Needham Buy
Mar-29-21 Upgrade Goldman Neutral → Buy
Sep-14-20 Initiated Goldman Neutral
Sep-14-20 Initiated Jefferies Buy
Sep-14-20 Initiated Piper Sandler Overweight
View All

Harmony Biosciences Holdings Inc Stock (HRMY) Latest News

pulisher
10:30 AM

Harmony Biosciences Holdings Inc. stock trend outlook and recovery pathIPO Watch & Free Fast Entry Momentum Trade Alerts - newser.com

10:30 AM
pulisher
10:19 AM

What Wall Street predicts for Harmony Biosciences Holdings Inc. stock priceWeekly Gains Report & Smart Swing Trading Techniques - newser.com

10:19 AM
pulisher
08:06 AM

Custom watchlist performance reports with Harmony Biosciences Holdings Inc.2025 Market Sentiment & AI Optimized Trade Strategies - newser.com

08:06 AM
pulisher
08:02 AM

Published on: 2025-10-13 07:02:21 - newser.com

08:02 AM
pulisher
Oct 12, 2025

Harmony Biosciences Hits 52-Week Low at $26.15 Amid Market Turbulence - Markets Mojo

Oct 12, 2025
pulisher
Oct 11, 2025

Harmony Biosciences Holdings, Inc. Experiences Revision in Stock Evaluation Amid Market Challenges - Markets Mojo

Oct 11, 2025
pulisher
Oct 10, 2025

Harmony Biosciences Forms Death Cross, Signaling Bearish Trend Ahead - Markets Mojo

Oct 10, 2025
pulisher
Oct 10, 2025

Does Harmony Biosciences Holdings Inc. show high probability of reboundGlobal Markets & Technical Buy Zone Confirmations - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Can Harmony Biosciences Holdings Inc. hit a new high this monthJuly 2025 Momentum & Accurate Trade Setup Notifications - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Using AI based signals to follow Harmony Biosciences Holdings Inc.July 2025 News Drivers & Daily Technical Forecast Reports - newser.com

Oct 10, 2025
pulisher
Oct 08, 2025

Harmony Biosciences stock hits 52-week low at $26.26 By Investing.com - Investing.com Nigeria

Oct 08, 2025
pulisher
Oct 08, 2025

What analysts say about Harmony Biosciences Holdings Inc stockEarnings Volatility Patterns & Amplify Gains With Picks - earlytimes.in

Oct 08, 2025
pulisher
Oct 08, 2025

Harmony Biosciences (NASDAQ:HRMY) Hits New 1-Year LowWhat's Next? - MarketBeat

Oct 08, 2025
pulisher
Oct 08, 2025

Robeco Institutional Asset Management B.V. Takes $1.48 Million Position in Harmony Biosciences Holdings, Inc. $HRMY - MarketBeat

Oct 08, 2025
pulisher
Oct 07, 2025

Top 3 Health Care Stocks That Are Preparing To Pump In Q4 - Sahm

Oct 07, 2025
pulisher
Oct 06, 2025

Is Harmony Biosciences (HRMY) the Oversold Biotech Stock to Buy Now? - MSN

Oct 06, 2025
pulisher
Oct 05, 2025

Using Bollinger Bands to evaluate Harmony Biosciences Holdings Inc.Weekly Trade Report & Weekly Breakout Watchlists - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Understanding Harmony Biosciences Holdings Inc.’s price movementOil Prices & Low Drawdown Investment Strategies - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

What drives Harmony Biosciences Holdings Inc stock priceSector Leadership Analysis & Master Stock Selection - earlytimes.in

Oct 05, 2025
pulisher
Oct 04, 2025

Harmony Biosciences’ Fragile X Trial Falls Short but Offers Key Insights - MyChesCo

Oct 04, 2025
pulisher
Oct 03, 2025

Exit strategy if you’re trapped in Harmony Biosciences Holdings Inc.July 2025 Trends & Stock Portfolio Risk Management - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

Harmony Biosciences Hits New 52-Week Low at $26.26 - Markets Mojo

Oct 02, 2025
pulisher
Oct 02, 2025

Harmony Biosciences (HRMY): Assessing Valuation After RECONNECT Trial Disappointment for ZYN002 in Fragile X Syndrome - Yahoo Finance

Oct 02, 2025
pulisher
Oct 01, 2025

H.C. Wainwright Reaffirms Buy on Harmony Biosciences Holdings, Inc. (HRMY) Despite Phase 3 Setback - MSN

Oct 01, 2025
pulisher
Sep 30, 2025

Harmony Biosciences Holdings, Inc. (HRMY) Q3 Earnings and Revenues Surpass Estimates - MSN

Sep 30, 2025
pulisher
Sep 29, 2025

10 Best Low Priced Growth Stocks to Buy Now - Insider Monkey

Sep 29, 2025
pulisher
Sep 29, 2025

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Receives Consensus Rating of “Buy” from Analysts - Defense World

Sep 29, 2025
pulisher
Sep 29, 2025

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Receives Consensus Rating of "Buy" from Analysts - MarketBeat

Sep 29, 2025
pulisher
Sep 29, 2025

Q3 EPS Estimate for Harmony Biosciences Boosted by Analyst - MarketBeat

Sep 29, 2025
pulisher
Sep 28, 2025

Wall Street Zen Downgrades Harmony Biosciences (NASDAQ:HRMY) to Hold - MarketBeat

Sep 28, 2025
pulisher
Sep 27, 2025

Harmony Biosciences Holdings Inc Stock Analysis and ForecastAutomated Trading Signals & Free Trend Following Techniques - Early Times

Sep 27, 2025
pulisher
Sep 26, 2025

Harmony Biosciences Hits 52-Week Low at $26.35 Amid Market Struggles - Markets Mojo

Sep 26, 2025
pulisher
Sep 26, 2025

HC Wainwright Has Positive Estimate for HRMY Q2 Earnings - MarketBeat

Sep 26, 2025
pulisher
Sep 26, 2025

Analysts Offer Insights on Healthcare Companies: Harmony Biosciences Holdings (HRMY) and Medtronic (MDT) - The Globe and Mail

Sep 26, 2025

Harmony Biosciences Holdings Inc Stock (HRMY) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Harmony Biosciences Holdings Inc Stock (HRMY) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Kapadia Sandip
CHIEF FINANCIAL OFFICER
Aug 15 '25
Sale
36.50
21,573
787,378
0
$85.13
price up icon 1.59%
$22.83
price up icon 7.21%
$32.80
price up icon 3.03%
$102.59
price up icon 0.56%
$165.04
price up icon 1.60%
biotechnology ONC
$330.86
price up icon 3.39%
Cap:     |  Volume (24h):